Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this narrative review, the researchers reported that the overall safety profile of drugs used for treating spondyloarthritis is generally good, with serious adverse events being rare, but emphasized the need for rheumatologists to tailor treatments and closely monitor patients for potential adverse events.

This study suggests that Cepharanthine, a monomer in traditional Chinese medicine, may help treat COVID-19 by affecting multiple signaling pathways, and that TNF and IL-17 inhibitors used in rheumatoid arthritis, ankylosing spondylitis, and gouty arthritis might also be beneficial.

This article explores how narratives around racial and ethnic minorities versus fat individuals during the Covid-19 pandemic influenced the framing of these groups as "at-risk," with disparities in blame and responsibility linked to structural racism and anti-obesity rhetoric.

This study developed an optimal gel-mask composition with nettle juice intended for treating telogen effluvium, determining the ideal concentrations for antioxidants and preservatives through extensive rheological and microbiological testing.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

In this study, researchers developed and tested hair gels using pectin from mango and coconut oil as a potential natural treatment for traction alopecia in black women, reporting stability in some formulations and rheological properties that may support their use in innovative phytocosmetics.

This study reviewed recent literature on Long COVID, examining cardiopulmonary, dermatological, neurological, and rheumatological symptoms and identifying risk factors like severe initial infection, comorbidities, and lack of prior vaccination.

In this study, researchers found no significant link between ABO blood type, rhesus factor, or genotype and premature graying of hair, but observed potential associations with lifestyle factors such as smoking and alcohol intake.

This study surveyed the use and potential toxicity of medicinal plants in the Fez-Meknes region of Morocco, documenting 59 toxic species used primarily for cosmetic purposes and minor illnesses, and identified hair loss and rheumatism as having the highest informant agreement ratios.

In this review, the authors noted that while baricitinib, a treatment for refractory rheumatoid arthritis and severe alopecia areata, shows promising efficacy, it may pose risks of serious infections and malignancy due to immune downregulation.

This case report highlights the first known instance of ANA-negative systemic lupus erythematosus presenting as spontaneous coronary artery dissection, emphasizing a need for rheumatological evaluation in such patients.

This study developed an emulgel containing Saw Palmetto extract and Sophora Japonica tincture for treating androgenic alopecia, optimizing its preparation process to enhance dispersion and rheological properties.

This research discusses the parallel clinical development of ritlecitinib, an oral Janus kinase 3/tyrosine kinase inhibitor, for treating conditions such as alopecia areata, vitiligo, ulcerative colitis, Crohn's disease, and rheumatoid arthritis. Results are not reported in the abstract.

This study reviews international perspectives on using platelet-rich plasma, stem cells, and exosomes, highlighting their expanding applications in fields like oncology, dermatology, neurology, and rheumatology, with an emphasis on ethical considerations and the need for further research.

The CSTAR registry, the largest in China for SLE, reports more than 25,000 patients registered since 2009, detailing demographics, clinical characteristics, and providing data for future studies.

This study found that the new SLICC classification criteria for systemic lupus erythematosus were more sensitive and resulted in fewer misclassifications than the current ACR criteria, although they had lower specificity.

This study observed that systemic lupus erythematosus may not be as uncommon among African Blacks as previously reported, highlighting the need for early aggressive treatment.

This case report describes an 8-year-old girl with Mixed Connective Tissue Disease who experienced remission after treatment with immunomodulator drugs, highlighting the diagnostic value of anti-U1 RNP antibody testing in children.

This study found that fibromyalgia prevalence is slightly higher in patients with systemic lupus erythematosus compared to those with arthritis, but fibromyalgia-ness does not bias the SLE Activity Questionnaire.

In this study, baricitinib improved the resolution of arthritis or rash in patients with systemic lupus erythematosus, but outcomes for skin involvement like alopecia were not reported.

This review discusses the development of Janus kinase inhibitors for dermatologic diseases and reports no new results; the authors note the need for further research on their efficacy and safety.

In this study, 93% of patients with inflammatory arthritis remained on the adalimumab biosimilar ABP 501 for 24 weeks after switching from the originator, with some switching back due to adverse reactions or reduced effectiveness.

Adequate steroid treatment needed to limit bone loss in PMR patients.

This study highlights the efforts of the Oyemam Autoimmune Foundation in raising awareness and supporting lupus patients in Ghana, amid challenges like misdiagnosis and insufficient healthcare resources, revealing the impact of their advocacy and counseling initiatives on patients' lives.

This article reviews the classification and treatment of cutaneous manifestations in systemic lupus erythematosus, highlighting the importance of monitoring for disease progression and reports no new clinical results.

This case report describes a teenager with Systemic Lupus Erythematosus experiencing neuropsychiatric symptoms, highlighting diagnostic criteria and laboratory findings, but reports no new treatment outcomes.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

This case study illustrates the classic dermatological signs of scurvy in a man with unusual dietary habits, showcasing the importance of recognizing and treating vitamin C deficiency in marginalized populations.

This study found that cedrol, administered orally, exhibited potential antiarthritic effects in rats by reducing inflammation, oxidative stress, and arthritis severity.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.